These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11077647)

  • 21. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
    Kaunitz AM;
    Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
    [No Abstract]   [Full Text] [Related]  

  • 22. Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception.
    Cromer BA; Lazebnik R; Rome E; Stager M; Bonny A; Ziegler J; Debanne SM
    Am J Obstet Gynecol; 2005 Jan; 192(1):42-7. PubMed ID: 15672001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monthly injectable contraceptive use by adolescents in Brazil: evaluation of clinical aspects.
    Guazzelli CA; Jacobucci MS; Barbieri M; Araújo FF; Moron AF
    Contraception; 2007 Jul; 76(1):45-8. PubMed ID: 17586136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injectable contraceptive, the promising alternative.
    Koetsawang S
    J Med Assoc Thai; 1975 Dec; 58(12):606-13. PubMed ID: 1206260
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
    Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S;
    Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Considerations in the choice of oral vs. transdermal hormone therapy: a review.
    Minkin MJ
    J Reprod Med; 2004 Apr; 49(4):311-20. PubMed ID: 15134159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in hormone delivery systems.
    Shulman LP; Nelson AL; Darney PD
    Am J Obstet Gynecol; 2004 Apr; 190(4 Suppl):S39-48. PubMed ID: 15105797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in contraception: new technology.
    Linn ES
    Int J Fertil Womens Med; 2003; 48(4):182-91. PubMed ID: 13677551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large-scale MPA injections.
    IPPF Med Bull; 1967; 1(5):3. PubMed ID: 12275354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New contraceptive methods.
    Plourd DM; Rayburn WF
    J Reprod Med; 2003 Sep; 48(9):665-71. PubMed ID: 14562628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone therapy. A year in review.
    Mayo Clin Womens Healthsource; 2003 Aug; 7(8):1-2. PubMed ID: 12925832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Painless Depo-medroxyprogesterone acetate (DMPA) injections using the 'pinch technique'.
    Fletcher H
    J Obstet Gynaecol; 2004 Aug; 24(5):562-3. PubMed ID: 15369941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaphylaxis from medroxyprogesterone acetate.
    Selo-Ojeme DO; Tillisi A; Welch CC
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1045-6. PubMed ID: 15121602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Same-day administration of depot-medroxyprogesterone acetate injection: a retrospective chart review.
    Balkus J; Miller L
    Contraception; 2005 May; 71(5):395-8. PubMed ID: 15854642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical investigation of medroxyprogesterone acetate and estradiol cypionate in contraceptive injection administered monthly].
    Rustrian A; Luyando H
    Ticitl; 1975 Sep; 14(3):98-100. PubMed ID: 12336077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
    Aktun H; Moroy P; Cakmak P; Yalcin HR; Mollamahmutoglu L; Danisman N
    Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statement on injectable contraception. Revised.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1992 Dec; 26(6):4-6. PubMed ID: 12346921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body composition during treatment with conjugated estrogens with and without medroxyprogesterone acetate: analysis of the women's Health, Osteoporosis, Progestin, Estrogen (HOPE) trial.
    Thorneycroft IH; Lindsay R; Pickar JH
    Am J Obstet Gynecol; 2007 Aug; 197(2):137.e1-7. PubMed ID: 17689624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.